Recursion Pharmaceuticals
RXRX
#4138
Rank
NZ$3.79 B
Marketcap
$9.76
Share price
-0.87%
Change (1 day)
-13.90%
Change (1 year)

EPS for Recursion Pharmaceuticals (RXRX)

EPS in 2023 (TTM): -$2.27

According to Recursion Pharmaceuticals's latest financial reports the company's current EPS (TTM) is -$2.36. In 2022 the company made an earnings per share (EPS) of -$2.35 a decrease over its 2021 EPS that were of -$2.00.

EPS history for Recursion Pharmaceuticals from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$2.27-3.43%
2022-$2.3517.39%
2021-$2.0050.85%
2020-$1.33